Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cholesterol lowering in atherosclerosis.

W V Brown1

  • 1Atlanta VA Medical Center, Medical Service, Decatur, Georgia 30033, USA.

The American Journal of Cardiology
|October 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Selective herbivory by Christmas beetles in response to intraspecific variation in Eucalyptus terpenoids.

Oecologia·2017
Same author

Dihydromatricariate-based triglycerides, glyceride ethers, and waxes in the australian soldier beetle,Chauliognathus lugubris (Coleoptera: Cantharidae).

Journal of chemical ecology·2013
Same author

Novel internally branched, internal alkenes as major components of the cuticular hydrocarbons of the primitive australian antNothomyrmecia macrops Clark (Hymenoptera: Formicidae).

Journal of chemical ecology·2013
Same author

Meal-induced increases in C-reactive protein, interleukin-6 and tumour necrosis factor α are attenuated by prandial + basal insulin in patients with Type 2 diabetes.

Diabetic medicine : a journal of the British Diabetic Association·2011
Same author

Landmark trials in lipid reduction.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006
Same author

Cardiovascular disease and lipoproteins: available evidence and remaining questions. Reactor panel and open forum.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006
Same journal

Real-World Effectiveness and Tolerability of Sacubitril/Valsartan in Octogenarian Patients With Heart Failure: Results From the PARACHUTER Study.

The American journal of cardiology·2026
Same journal

ECG-Guided Conduction Pathways as a Lever to Shorten Post-TAVI Hospitalization.

The American journal of cardiology·2026
Same journal

Cystatin-C versus creatinine and kidney function in heart failure with preserved ejection fraction: a SOGALDI-PEF analysis.

The American journal of cardiology·2026
Same journal

Balloon-expandable versus Self-expanding Valves in Patients with Small Aortic Annuli Undergoing Transcatheter Aortic Valve Replacement.

The American journal of cardiology·2026
Same journal

Drug-Coated Balloons versus Drug-Eluting Stents following Coronary Atherectomy in Severely Calcified Lesions: A Systematic Review and Meta-Analysis.

The American journal of cardiology·2026
Same journal

Prehospital Statin Therapy and Outcomes in ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.

The American journal of cardiology·2026
See all related articles

Statin therapy significantly lowers low-density lipoprotein (LDL) cholesterol, reducing cardiovascular events and improving survival in patients with coronary artery disease. However, many patients do not achieve recommended LDL goals, indicating undertreatment with statins.

Area of Science:

  • Cardiology
  • Pharmacology
  • Preventive Medicine

Background:

  • Lipid-lowering therapy with statins is proven to reduce cardiovascular disease progression, myocardial infarction, and mortality.
  • Lowering low-density lipoprotein (LDL) cholesterol in patients with coronary artery disease (CAD) demonstrably reduces cardiovascular events, with lower LDL levels correlating to lower event rates.

Purpose of the Study:

  • To review the current evidence supporting LDL cholesterol reduction goals in patients with CAD.
  • To discuss the implications of the Treating to New Targets study on LDL cholesterol targets.
  • To highlight the gap between current NCEP recommendations and actual clinical practice regarding statin therapy.

Main Methods:

  • Review of large-scale clinical trials on statin therapy and lipid-lowering.

Related Experiment Videos

  • Analysis of data regarding achievement of National Cholesterol Education Program (NCEP) lipid goals in patients with CAD.
  • Discussion of the potential benefits of further LDL cholesterol reduction.

    • Main Results:

    • Current evidence supports NCEP recommendations to lower LDL cholesterol to at least 100 mg/dL in patients with CAD.
    • A significant percentage of patients with CAD (up to 82%) do not meet current NCEP lipid goals.
    • A substantial proportion of patients (up to 55%) require more than a 30 mg/dL reduction in LDL cholesterol to reach the NCEP goal.

    Conclusions:

    • Many patients with coronary artery disease are not adequately treated with statins or receive insufficient doses to meet lipid goals.
    • Aggressive lipid lowering, while beneficial, is not yet standard practice despite evidence supporting its efficacy.
    • Further research, such as the Treating to New Targets study, is needed to determine optimal LDL cholesterol targets for maximal cardiovascular event reduction.